Floatz logo

Human Immunoglobulins

Common Variable Immunodeficiency

Grifols Therapeutics LLCother_biologicalPhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Common Variable Immunodeficiency cohort.

Asset / SponsorPhaseRating
Conestat Alfa
IMMUNOe Research Centers
Phase 4BB
Thiotepa
University of Florida
Phase 2BB
Melphalan
Paul Szabolcs
Phase 2CCC
Fludarabine
Paul Szabolcs
Phase 2CCC
Alemtuzumab
Paul Szabolcs
Phase 2CCC

View all 18 →

Same molecule, other indications

Human Immunoglobulins is also rated in:

Alzheimer diseaseDormant
BB
Indicative · Phase 3
70 / 100
View asset →
epilepsyDormant
BB
Indicative · Phase 4
66 / 100
View asset →
plasma cell myelomaActive
BB
Indicative · Phase 2/3
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →